Crossmark

Immunosuppressive therapy for aplastic anemia: a single-center experience from western India

Crossref DOI link: https://doi.org/10.1007/s00277-018-3487-2

Published Online: 2018-09-01

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shah, Sandip https://orcid.org/0000-0003-1008-5258
Jain, Preetam

Shah, Kamlesh

Patel, Kinnari

Parikh, Sonia

Patel, Apurva

Panchal, Harsha

Anand, Asha
License Information

Text and Data Mining valid from 2018-09-01
More Information

Article History

Received: 30 January 2018

Accepted: 25 August 2018

First Online: 1 September 2018

Compliance with ethical standards

: Approval of the institutional ethics committee was obtained prior to the conduct of the study. For this type of study, formal consent is not required. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).

: The authors declare that they have no conflict of interest.